Table 2 Cellular proteins altered after purified rhodomyrtone treatment of Streptococcus pneumoniae.

From: Integrated proteomic and metabolomic analysis reveals that rhodomyrtone reduces the capsule in Streptococcus pneumoniae

Spot #

Accession numbera

Protein annotation

Mascot score

Coverage (%)

Fold changeb

p-valuec

4 C

Q8DMY8

Cysteine synthase

180

21

0.36

0.032

10 C

Q8DN31

Arginine deiminase

316

19

0.41

0.018

12 C, 21 C

P65608

Ornithine carbamoyltransferase

158

23

0.31

0.021

4 A

Q97NL1

Glyceraldehyde-3-phosphate dehydrogenase, type I

308

30

0.29

0.019

6 A

P66942

Triosephosphate isomerase

104

24

0.33

0.028

11 A, 6 C, 11 C

P0A3M9, P0A3N0

L-lactate dehydrogenase

101

22

0.44

0.045

14 A

P58313

UTP-glucose-1-phosphate uridylyltransferase

103

31

0.38

0.010

1 C

Q8DRG7

Glycosyltransferase, family 2

98

25

0.30

0.013

16 C

Q8DR15

3-ketoacyl-(acyl-carrier-protein) reductase

95

20

0.37

0.023

7 C

Q8DPM2

DNA gyrase A subunit

96

21

0.40

0.039

5 C

P64031

Elongation factor Tu

517

26

0.29

0.009

6B

Q97SV1

50 S ribosomal protein L5

87

18

1.93

0.034

3D

Q8DN74

Glucose-6-phosphate isomerase

83

19

2.41

0.022

7B

P64022

Elongation factor G

348

24

2.75

0.043

  1. aAccession numbers correspond to UniProt. bThe values represent the intensities ratio between rhodomyrtone treatment and control for each spot. Values > 1 indicate an increase in protein abundance. Values < 1 indicate a decrease in protein abundance. cData were analyzed using the Student’s t-test. P-values < 0.05 were considered statistically significant.
Back to article page